Editas Medicine Receives EMA’s Orphan Medicinal Product Designation for EDIT-101 for the Treatment of LCA10 – GlobeNewswire (press release)
Press Telegraph |
Editas Medicine Receives EMA’s Orphan Medicinal Product Designation for EDIT-101 for the Treatment of LCA10
GlobeNewswire (press release) 26, 2017 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced the European Medicines Agency (EMA) granted Orphan Medicinal Product designation to EDIT-101, a pre-clinical, CRISPR-based … Editas Medicine, Inc. (NASDAQ:EDIT) Moving Today – Down $0.85First News 24 |
Phys.Org |
Team develops gene circuit design strategy to advance synthetic biology
Phys.Org “With the increase of circuit complexity, the lack of predictive design guidelines has become a major challenge in realizing the potential of synthetic biology,” said Lu, who also is affiliated with the Carl R. Woese Institute for Genomic Biology and … |
|
Illinois researchers develop gene circuit design strategy to advance synthetic biology
EurekAlert (press release) “With the increase of circuit complexity, the lack of predictive design guidelines has become a major challenge in realizing the potential of synthetic biology,” said Lu, who also is affiliated with the Carl R. Woese Institute for Genomic Biology and … |
Pork Magazine |
‘CRISPR‘ Bacon: Pigs could soon save millions more lives
Pork Magazine An article in the Huffington Post reported that the research team, led by a biotechnology company called eGenesis, “has successfully used a powerful gene-editing technique known as CRISPR to modify the DNA in pig cells and remove a number of viruses … |
Science Daily |
Amount of water in stem cells can determine its fate as fat or bone
Science Daily “The findings from this study add a fascinating new tool to our understanding and utilization of stem cell biology for regenerative medicine,” says Praveen Arany, DDS, PhD, co-author and assistant professor in the Department of Oral Biology in the … |